Posez n’importe quelle question sur les cours, conférences, exercices, recherches, actualités, etc. de l’EPFL ou essayez les exemples de questions ci-dessous.
AVERTISSEMENT : Le chatbot Graph n'est pas programmé pour fournir des réponses explicites ou catégoriques à vos questions. Il transforme plutôt vos questions en demandes API qui sont distribuées aux différents services informatiques officiellement administrés par l'EPFL. Son but est uniquement de collecter et de recommander des références pertinentes à des contenus que vous pouvez explorer pour vous aider à répondre à vos questions.
Next-generation sequencing (NGS) has revolutionized genome biology by enabling rapid whole-genome sequencing (WGS) and driving its adoption in research and clinical settings. However, the high-throughput nature of NGS and the complexity of downstream analyses demand robust computational solutions. We present GeNePi, a modular bioinformatic pipeline for efficient and accurate analysis of WGS short paired-end reads. GeNePi is a genomics analysis pipeline built on the Nextflow framework, integrating graphics processing unit (GPU)-accelerated algorithms from NVIDIA Clara Parabricks to enable high-performance variant discovery. The pipeline supports multiple workflow configurations and automates the detection of a broad range of genomic variants, including single-nucleotide variants and small insertions/deletions via GPU-accelerated HaplotypeCaller, copy number variants (CNVs) using CNVkit, and structural variants through a consensus approach combining Manta, Lumpy, BreakDancer, and CNVnator. Additionally, GeNePi incorporates MELT for the detection of mobile element insertions, providing a comprehensive framework for variant discovery and characterization. Benchmarking on synthetic and real datasets demonstrates high accuracy and performance comparable to state-of-the-art tools such as Genome Analysis ToolKit (GATK), establishing GeNePi as a scalable solution for comprehensive WGS analysis. These features make GeNePi a valuable instrument for large-scale analyses in both research and clinical contexts, representing a key step towards the establishment of National Centers for Computational and Technological Medicine.